Reis, Edimara S.
Mastellos, Dimitrios C.
Ricklin, Daniel
Mantovani, Alberto
Lambris, John D.
Article History
First Online: 18 September 2017
Competing interests
: J.D.L. and D.R. are inventors of patents or patent applications that describe the use of complement inhibitors for therapeutic purposes. J.D.L. is the founder of Amyndas Pharmaceuticals, which is developing complement inhibitors. E.S.R. and D.C.M. declare no financial interest or conflict.